Adaptive Biotechnologies Corp (ADPT) kicked off at the price of $4.44: Venture capitalists have an exciting new opportunity

Adaptive Biotechnologies Corp (NASDAQ: ADPT) kicked off on November 20, 2023, at the price of $4.34, up 3.02% from the previous trading day. During the day, the shares moved up to $4.645 and dropped to $4.22 before settling in for the closing price of $4.31. Over the past 52 weeks, ADPT has traded in a range of $2.61-$10.79.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


During the last 5-year period, the sales growth of Healthcare Sector giant was 38.04%. While this was happening, its average annual earnings per share was recorded 1.71%. With a float of $141.61 million, this company’s outstanding shares have now reached $143.11 million.

Let’s determine the extent of company efficiency that accounts for 790 employees. In terms of profitability, gross margin is +57.46, operating margin of -106.94, and the pretax margin is -108.13.

Adaptive Biotechnologies Corp (ADPT) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 2.18%, while institutional ownership is 94.78%. The most recent insider transaction that took place on Nov 16, was worth 1,070. In this transaction Principal Accounting Officer of this company sold 259 shares at a rate of $4.13, taking the stock ownership to the 87,305 shares. Before that another transaction happened on Aug 08, when Company’s Chief Commercial Officer, MRD sold 10,550 for $6.54, making the entire transaction worth $68,997. This insider now owns 214,808 shares in total.

Adaptive Biotechnologies Corp (ADPT) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.35 earnings per share (EPS), lower than consensus estimate (set at -$0.34) by -$0.01. This company achieved a net margin of -108.03 while generating a return on equity of -37.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 1.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.60% during the next five years compared to -32.30% drop over the previous five years of trading.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators

Take a look at Adaptive Biotechnologies Corp’s (ADPT) current performance indicators. Last quarter, stock had a quick ratio of 4.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.58.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.36, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.15 in one year’s time.

Technical Analysis of Adaptive Biotechnologies Corp (ADPT)

Looking closely at Adaptive Biotechnologies Corp (NASDAQ: ADPT), its last 5-days average volume was 1.75 million, which is a jump from its year-to-date volume of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 71.03%. Additionally, its Average True Range was 0.43.

During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 31.08%, which indicates a significant decrease from 68.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 132.06% in the past 14 days, which was higher than the 80.61% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.79, while its 200-day Moving Average is $6.87. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $4.65. Second resistance stands at $4.86. The third major resistance level sits at $5.08. If the price goes on to break the first support level at $4.22, it is likely to go to the next support level at $4.01. Now, if the price goes above the second support level, the third support stands at $3.80.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats

The company with the Market Capitalisation of 642.78 million has total of 144,773K Shares Outstanding. Its annual sales at the moment are 185,310 K in contrast with the sum of -200,190 K annual income. Company’s last quarter sales were recorded 37,920 K and last quarter income was -50,300 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

HashiCorp Inc (HCP) last year’s performance of -14.87% is a clear signal for an entertaining trading season.

On November 24, 2023, HashiCorp Inc (NASDAQ: HCP) opened at $20.87, higher 1.96% from the last session. During the day, the shares moved up...

Kyndryl Holdings Inc (KD) is ready for next Episode as it posted an annual sales of 17,026 M

A new trading day began on November 24, 2023, with Kyndryl Holdings Inc (NYSE: KD) stock priced at $18.05, down -0.39% from the previous...

Atmos Energy Corp. (ATO) is expecting -4.84% growth in the next quarter: What can investors do to maximize their returns?

Atmos Energy Corp. (NYSE: ATO) kicked off on November 24, 2023, at the price of $112.31, down -0.93% from the previous trading day. During...


Please enter your comment!
Please enter your name here